SPOTLIGHT -
The FDA has given Bausch & Lomb approval to market its Active EyetrackingSystem in the United States.
Mental health and ophthalmology
Claris Bio's journey toward treating neurotrophic keratitis
Connecticut ophthalmologist sentenced to prison for health care fraud scheme
(EyePod) From idea to impact: Navigating ophthalmic innovation
Prevent Blindness kicks off ‘It Started With an Eye Exam’
ARVO 2024: Abnormal subendothelial matrix exacerbates choroidal endothelial cell death in early AMD